NCT07074054View on ClinicalTrials.gov

Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

April 15, 2024

Study Completion Date

March 30, 2025

Conditions
Presence of Retinal FluidChanges in Macular Pigment Optical Density
Trial Locations (1)

Unknown

University of Naples, Federico II, Napoli

All Listed Sponsors
lead

Federico II University

OTHER

NCT07074054 - Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes | Biotech Hunter | Biotech Hunter